Cardiac tachyarrhythmia therapy selection based on patient response information

• US 7,228,173 B2
• Filed: 11/23/2004
• Issued: 06/05/2007
• Est. Priority Date: 11/23/2004
• Status: Expired due to Fees

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Cazares, Shelley Marie
• Primary Examiner(s): Pezzuto; Robert E.
• Assistant Examiner(s): MALAMUD, DEBORAH LESLIE
• Application Number:
  US10/995,655
• Publication Number:
  US 20060111751A1
• Time in Patent Office: 924 Days
• Field of Search: 607/14, 607/4, 607/9, 600/509, 600/510, 600/518, 128/920
• US Class Current: 607/14
• CPC Class Codes: A61B 5/35 by template matching
• CPC Class Codes: A61B 5/361 Detecting fibrillation
• CPC Class Codes: A61B 5/363 Detecting tachycardia or bradycardia
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/365 controlled by a physiological parameter, e.g. heart potential evoked response A61N1/371
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

Cardiac treatment methods and devices providing templates representative of past tachyarrythmia events, each template associated with a therapy. A cardiac waveform is detected, and if it corresponds to a particular template associated with a previous therapy that was satisfactory in terminating a past event, the previous therapy is delivered again. If unsatisfactory, the previous therapy is eliminated as an option. If, for example, the previous therapy was an antitachycardia pacing therapy unsatisfactory in terminating the past tachyarrythmia event, delivery of the antitachycardia pacing therapy is eliminated as an option. Instead of ATP therapy, one or more of a cardioversion, defibrillation, or alternate anti-tachycardia pacing therapy may be associated with the particular template. Cardiac waveforms and templates may correspond in terms of one or more of morphology, timing, drug regimen, medication, neural activity, patient activity, hemodynamic status, cardiac tissue impedance, transthoracic impedance, or other information corresponding to the episode.

Claims

1. A method, comprising:

providing one or more templates representative of one or more of a patient'"'"'s past tachyarrythmia events, each of the templates associated with a therapy to treat tachyarrythmia events;

detecting a cardiac waveform; and

if the cardiac waveform corresponds to a particular template of the one or more templates, determining if a previous therapy associated with the particular template was satisfactory in terminating a past tachyarrhythmia event associated with the particular template, and if determined satisfactory, delivering the previous therapy, and if determined unsatisfactory, eliminating the previous therapy as an option for treating a subsequent tachyarrhythmia event associated with the particular template.

2. The method of claim 1, wherein if the previous therapy was an antitachycardia pacing therapy determined to be unsatisfactory in terminating the past tachyarrythmia event, eliminating delivery of the antitachycardia pacing therapy as an option for treating a subsequent tachyarrhythmia event and associating one or more of a cardioversion, a defibrillation therapy, or an alternate anti-tachycardia pacing therapy with the particular template.

3. The method of claim 1, wherein the correspondence between the cardiac waveform and the particular template is a correspondence in terms of morphology.

4. The method of claim 1, wherein the correspondence between the cardiac waveform and the particular template is a correspondence in terms of timing.

5. The method of claim 1, wherein the correspondence between the cardiac waveform and the particular template is a correspondence in terms of a) drug regimen and morphology or b) drug regimen and timing.

6. The method of claim 1, comprising adding a new template to the one or more templates by replacing an oldest template of the one or more templates with the new template.

7. The method of claim 1, comprising associating one or more of medication information, neural activity information, patient activity information, hemodynamic status information, cardiac tissue impedance information, and transthoracic impedance information with the one or more templates.

8. The method of claim 1, comprising deleting a particular template of the one or more templates if the particular template is older than a predetermined age, or has not corresponded to a cardiac waveform for a predetermined time, or has corresponded to past arrhythmias least frequently relative to other templates, or represents a heart-rate similar to other existing templates.

9. The method of claim 1, comprising deleting a particular template of the one or more templates if the particular template is associated with a drug regimen that no longer matches the patient'"'"'s current drug regimen.

10. The method of claim 1, wherein the detected cardiac waveform is indicative of an arrhythmia in the ventricles, of ventricular or supra-ventricular origin.

11. The method of claim 1, wherein the detected cardiac waveform is indicative of an arrhythmia in the atria.

12. The method of claim 1, further comprising arbitrating between two or more templates if the cardiac waveform corresponds to two or more templates.

13. The method of claim 1, further comprising, if the cardiac waveform corresponds to two or more templates, selecting a template of the two or more templates associated with a treatment satisfactory in terminating the past tachyarrhythmia event, and delivering its associated tachyarrhythmia therapy.

14. The method of claim 1, further comprising, if the cardiac waveform corresponds to two or more templates, selecting a most recently used or generated template associated with a treatment satisfactory in terminating the past tachyarrhythmia event, and delivering its associated tachyarrhythmia therapy.

15. The method of claim 1, further comprising, if the cardiac waveform corresponds to two or more templates, selecting the most frequently matched template associated with a treatment satisfactory in terminating the past tachyarrhythmia event, and delivering its associated tachyarrhythmia therapy.

16. The method of claim 1, further comprising, if the cardiac waveform corresponds to two or more templates, selecting the template associated with a treatment satisfactory in terminating the past tachyarrhythmia event whose rate information most closely corresponds to the detected cardiac waveform, and delivering its associated tachyarrhythmia therapy.

17. The method of claim 1, further comprising, if the cardiac waveform corresponds to two or more templates, selecting the template associated with one or more of a patient'"'"'s drug regimen, neural activity, patient activity, hemodynamic state, transthoracic impedance, and cardiac tissue impedance similar to the patient'"'"'s current status.

18. The method of claim 1, further comprising associating the particular template with a new therapy if the previous therapy was unsatisfactory.

19. The method of claim 18, wherein the new therapy comprises an anti-tachycardia pacing therapy of substantially equivalent aggression in terms of energy or coupling interval.

20. The method of claim 18, wherein the new therapy comprises an anti-tachycardia pacing therapy of greater aggression in terms of energy or coupling interval.

21. The method of claim 18, wherein the new therapy comprises a cardioversion or defibrillation therapy.

22. A method, comprising:

providing one or more templates representative of one or more of a patient'"'"'s past tachyarrythmia events, each of the templates associated with a therapy delivered to treat a past tachyarrythmia event, the one or more templates comprising a low-rate template;

detecting a cardiac waveform;

determining that the cardiac waveform is indicative of a high-rate tachyarrythmia event having one or both of a morphology and timing corresponding to the low-rate template; and

determining if the delivered therapy associated with the low-rate template was satisfactory in terminating the past tachyarrythmia event associated with the low-rate template, and if determined satisfactory, delivering the therapy associated with the low-rate template to treat the high-rate tachyarrythmia event.

23. The method of claim 22, further comprising delivering a therapy different from the therapy associated with the low-rate template if the delivered therapy associated with the low-rate template was unsatisfactory in terminating the past ventricular tachyarrythmia event associated with the low-rate template.

24. A medical system, comprising:

a cardiac therapy system configured to deliver a cardiac therapy to a patient;

a detector system configured to detect a cardiac waveform associated with a tachyarrhythmia; and

a template processor coupled to the detector system and the cardiac therapy system, the template processor configured to provide one or more templates representative of one or more of a patient'"'"'s past tachyarrythmia events, each of the templates associated with a therapy to treat tachyarrythmia events, and, if the cardiac waveform corresponds to a particular template of the one or more templates, the template processor configured to determine if a previous therapy associated with the particular template was satisfactory in terminating a past tachyarrhythmia event corresponding to the particular template, and if determined satisfactory, prompt the cardiac therapy system to deliver the previous therapy, and if determined unsatisfactory, eliminate the previous therapy as an option for treating a subsequent tachyarrhythmia event associated with the particular template, and prompt the cardiac therapy system to deliver a different therapy.

25. The system of claim 24, wherein the cardiac therapy system is configured to deliver an anti-tachycardia pacing therapy to the patient to treat the tachyarrhythmia and determine one or both of the effectiveness and satisfaction of the anti-tachycardia pacing therapy.

26. The system of claim 24, comprising a patient activity sensor configured to provide patient activity information associated with tachyarrhythmia episodes to the template processor.

27. The system of claim 24, comprising a neural activity sensor configured to provide patient neural activity information associated with tachyarrhythmia episodes to the template processor.

28. The system of claim 24, comprising a transthoracic impedance sensor configured to provide patient transthoracic impedance information associated with tachyarrhythmia episodes to the template processor.

29. The system of claim 24, comprising an accelerometer configured to provide acceleration information associated with tachyarrhythmia episodes to the template processor.

30. The system of claim 24, comprising a cardiac tissue impedance sensing system configured to provide patient cardiac tissue impedance information associated with tachyarrhythmia episodes to the template processor.

31. The system of claim 24, comprising a hemodynamic status sensor configured to provide patient hemodynamic status information associated with tachyarrhythmia episodes.

32. A cardiac device, comprising:

means for providing one or more templates representative of one or more of a patient'"'"'s past tachyarrythmia events, each of the templates associated with a therapy to treat tachyarrythmia events;

means for detecting a cardiac waveform;

means for determining if a previous therapy associated with a particular template of the one or more templates was satisfactory in terminating a past tachyarrhythmia event associated with the particular template if the cardiac waveform corresponds to the particular template; and

means for eliminating the previous therapy as an option for treating a subsequent tachyarrhythmia event associated with the particular template if the previous therapy was determined unsatisfactory.